Abcuro Adds $66M to Try Again in Rare Inflammatory Disorder With No Approved Drugs – MedCity News
By Frank Vinluan Publication Date: 2026-08-23 17:34:00 Immunotherapy developer Abcuro received disappointing news this year as its lead drug candidate…
Tag: 66M
Abcuro secures $66m to support clinical trial of ulviprubart for IBM
By Salong Debbarma Publication Date: 2026-08-19 10:30:00 US-based biotechnology company Abcuro has closed a $66m Series D funding round to…
“We want to go head-to-head with Microsoft and Okta”: NewCore emerges with $66M to rebuild identity security | CTech
By Meir Orbach Publication Date: 2026-06-15 13:00:00 Israeli cybersecurity startup NewCore came out of stealth on Monday with fundraising rounds…
Intel’s new CEO lands $66M pay deal, with stock performance conditions
In a nutshell: As Intel prepares for the arrival of its new CEO, Lip-Bu Tan, a recent regulatory filing has…
Intel’s new CEO to get $1m salary, $66m stock grants – Tech in Asia
Intel’s new CEO to get $1m salary, $66m stock grants Tech in Asia Article Source https://www.techinasia.com/news/intels-new-ceo-to-get-1m-salary-66m-stock-grants